Industrial Microbiology Market (By Product: Instrument and Systems, Consumables; By Application; By Test Type; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The global industrial microbiology market size was estimated at around USD 10.1 billion in 2021 and it is projected to hit around USD 21.4 billion by 2030, growing at a CAGR of 8.7% from 2022 to 2030.

Industrial Microbiology Market Size 2021 to 2030

The growth of biotechnology in the past few years has led to advancements in the field of industrial microbiology. This biotechnology branch applies microbial knowledge to create industrial products with high yields. The continuous use of these microorganisms for many applications such as medical (for production of drugs, vaccines, hormones), food (for fermentation, dairy products, organic compounds), environment (for water treatment & purification, soil testing), and many more have driven the market in the past years.

With the developments in quality standards for all products in recent years, various industries have also employed the use of microbiology testing methods. These stringent and necessitated testing requirements to maintain the integrity and quality control of the product offerings are expected to boost the industrial microbiology market in the years to come. Moreover, the understanding of molecular biology coupled with genetic technologies has posed a positive impact on microbiological applications for the development of novel diagnostics methods. The COVID-19 pandemic has also bolstered market growth. For example, in a published January 2022 research article, a paper-based biosensor technology was devised for the detection of SARS-CoV2 in human saliva. The researchers from Brigham Young University, USA used E.coli lysate for the detection of SARS-CoV2 RNA with a bioluminescent output.

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 10.1 billion
Revenue Forecast by 2030 USD 21.4 billion
Growth rate from 2022 to 2030 CAGR of 8.7%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation Product, Application, Test Type, End-user, Region
Companies Covered

Thermo Fisher Scientific Inc., Eurofins Scientific Inc., bioMérieux S.A., Merck KGaA, Charles River Laboratories International, Inc., Bruker Corporation, Bio-Rad Laboratories, Inc.

 

The industrial microbiology market has various applications in multiple industries, a few of these are;

  • Pharmaceutical & biotechnology industries,
  • Food & beverage industries,
  • Agriculture & environmental industries,
  • Cosmetics & personal care industries,
  • Others

For pharmaceutical & biotechnology industries, rigorous quality standards are to be maintained during the manufacturing process. These standards are maintained via different methods, one such method is the environmental monitoring process which determines the quality and sterility of the controlled production environment. Environmental monitoring evaluates the microbial load of air, surfaces and personnel and verifies the established quality standards. The food & beverage industry heavily relies on industrial microbiology testing techniques to eliminate any possible pathogens and toxins in the products and protect the customer from ingestion of microbes.

Furthermore, the agriculture & environmental industry’s emphasis on microbiology testing for assessing the health of plants, air, soil, and water has increased its application. Moreover, as much personal care & cosmetics products are readily available over the counter (OTC), quality control plays an important role. The microbiology quality standards for such products need to comply with regulatory guidelines. Another application area such as veterinary health, hospital hygiene, and microbial resistance testing is also of high importance as it can be associated with the incidence of diseases that may increase the mortality rates.  

The continuous demand for microbiology testing solutions by multiple end-users has created numerous market opportunities for major players to capitalize. Launch of new systems, reagents & products, partnerships, expansion or opening of new facilities has been the business initiatives by key players. For example, Charles River Laboratories International, Inc. announced in May 2022 that it has opened a new facility in Germany. This facility is a center for the microbial solution business of the company in eastern and central Europe.

Key Players

  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific Inc.
  • bioMérieux S.A.
  • Merck KGaA
  • Charles River Laboratories International, Inc.
  • Bruker Corporation
  • Bio-Rad Laboratories, Inc.

Market Segmentation

  • By Product
    • Instrument and Systems
    • Consumables
  • By Application
    • Pharmaceutical & Biotechnological Industries
    • Food & Beverage Industries
    • Agriculture & Environmental Industries 
    • Cosmetics & Personal Care Industries
    • Others
  • By Test Type
    • Sterility Testing
    • Microbial Limit Detection
    • Bio-burden Testing
    • Environment Testing
    • Others
  • By End-user
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnological Companies 
    • Hospitals & Clinical Diagnostic Centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Industrial Microbiology Market 

5.1. COVID-19 Landscape: Industrial Microbiology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Industrial Microbiology Market, By Product

8.1. Industrial Microbiology Market, by Product, 2022-2030

8.1.1. Instrument and Systems

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Consumables

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Industrial Microbiology Market, By Application

9.1. Industrial Microbiology Market, by Application, 2022-2030

9.1.1. Pharmaceutical & Biotechnological Industries

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Food & Beverage Industries

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Agriculture & Environmental Industries

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Cosmetics & Personal Care Industries

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Industrial Microbiology Market, By Test Type 

10.1. Industrial Microbiology Market, by Test Type, 2022-2030

10.1.1. Sterility Testing

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Microbial Limit Detection

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Bio-burden Testing

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Environment Testing

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Industrial Microbiology Market, By End-user 

11.1. Industrial Microbiology Market, by End-user, 2022-2030

11.1.1. Academic & Research Institutes

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Pharmaceutical & Biotechnological Companies

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Hospitals & Clinical Diagnostic Centers

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Industrial Microbiology Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.1.4. Market Revenue and Forecast, by End-user (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End-user (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Test Type (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End-user (2017-2030)

Chapter 13. Company Profiles

13.1. Thermo Fisher Scientific Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Eurofins Scientific Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. bioMérieux S.A.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Merck KGaA

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Charles River Laboratories International, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Bruker Corporation

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Bio-Rad Laboratories, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers